Brand Name
Zarontin
Generic Name
Ethosuximide
View Brand Information FDA approval date: September 22, 2000
Classification: Anti-epileptic Agent
Form: Capsule, Solution
What is Zarontin (Ethosuximide)?
Zarontin is indicated for the control of absence epilepsy.
Approved To Treat
Save this treatment for later
Not sure about your diagnosis?
Related Clinical Trials
A Comparative Study to Assess Safety and Effectiveness of Ethosuximide and Pentoxifylline in the Treatment of Abdominal Pain Related to Irritable Bowel Syndrome
Summary: Ethosuximide and pentoxifylline in the treatment of abdominal pain related to irritable bowel syndrome